NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品编号 06697999 持证商 SCHAPER & BRÜMMER GmbH & Co. KG 包装规格 100 St Packungsnorm N3 产品名 Esberitox Tabletten 剂型 Tabletten Pfl. Arzneimittel ja 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/produkt/esberitox-tabletten-100-st-06697999.html
产品名称:ZIRABEV上市时间:02/17/2023NDA/ANDA/BLA:761099持证商:PFIZER INCNDC:0069-0315-01,0069-0342-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761099s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/761099Orig1s000ltr.pdf
产品名称:MVASI上市时间:02/17/2023NDA/ANDA/BLA:761028持证商:AMGEN INCNDC:55513-207-01,55513-206-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761028s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/761028Orig1s000ltr.pdf
产品名称:SYFOVRE 上市时间:02/17/2023NDA/ANDA/BLA:217171持证商:APELLIS PHARMSNDC:73606-020-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217171s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217171Orig1s000ltr.pdf
产品名称:FILSPARI 上市时间:02/17/2023NDA/ANDA/BLA:216403持证商:TRAVERENDC:68974-200-30,68974-400-30说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216403s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/216403Orig1s000ltr.pdf
产品名称:AUSTEDO XR 上市时间:02/17/2023NDA/ANDA/BLA:216354持证商:TEVA NEUROSCIENCE INCNDC:68546-470-56,68546-471-56,68546-472-56,68546-490-42,68546-490-52说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216354s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/216354Orig1s...
产品名称:SPINRAZ 上市时间:02/17/2023NDA/ANDA/BLA:209531持证商:BIOGEN IDECNDC:64406-058-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209531lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/209531Orig1s000ltr.pdf
产品名称:LAMZEDEBLA 上市时间:02/16/2023NDA/ANDA/BLA:761278持证商:CHIESI FARMACEUTICI SPANDC:10122-180-02,10122-180-05,10122-180-10说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761278s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761278Orig1s000ltr.pdf
产品名称:CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE上市时间:02/16/2023NDA/ANDA/BLA:210542持证商:ZYDUS PHARMS USA INCNDC:说明书:批准信:
产品名称:GABAPENTIN上市时间:02/16/2023NDA/ANDA/BLA:203934持证商:ZYDUS PHARMS USA INCNDC:说明书:批准信:
产品名称:ZETONN 上市时间:02/16/2023NDA/ANDA/BLA:202129持证商:COVISNDC:70515-737-60说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202129s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202129s000ltr.pdf